CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- ARS Other Annual Report to Security Holders
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market buy 10% owner bought 387,393 shares at $0.71 ($276,366)
- 4 Open-market buy 10% owner bought 25,000 shares at $0.75 ($18,690)
- 4 Open-market buy 10% owner bought 100,000 shares at $0.75 ($74,820)
- 4 Open-market buy 10% owner bought 736,105 shares at an average $0.71 ($520,599)
- 4 Open-market buy 10% owner bought 1,034,118 shares at $0.61 ($628,847)
- UPLOAD Other SEC-generated Letter
- S-4 Deal Registration Statement - Business Combination
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 5 of 21 · 404 filings